Privia Health Files 8-K

Ticker: PRVA · Form: 8-K · Filed: Jan 13, 2025 · CIK: 1759655

Privia Health Group, Inc. 8-K Filing Summary
FieldDetail
CompanyPrivia Health Group, Inc. (PRVA)
Form Type8-K
Filed DateJan 13, 2025
Risk Levellow
Pages2
Reading Time2 min
Key Dollar Amounts$0.01
Sentimentneutral

Sentiment: neutral

Topics: sec-filing, 8-k, reporting

Related Tickers: PRVA

TL;DR

PRVA filed an 8-K, standard reporting, no major news.

AI Summary

Privia Health Group, Inc. filed an 8-K on January 13, 2025, reporting a Regulation FD Disclosure and Financial Statements and Exhibits. The filing does not contain specific financial figures or material events beyond the standard reporting requirements for this form.

Why It Matters

This 8-K filing indicates Privia Health Group, Inc. is adhering to its reporting obligations with the SEC, which is standard practice for publicly traded companies.

Risk Assessment

Risk Level: low — The filing is a routine 8-K for reporting disclosures and exhibits, with no indication of significant new risks or material events.

Key Players & Entities

  • Privia Health Group, Inc. (company) — Registrant
  • January 13, 2025 (date) — Date of earliest event reported
  • 001-40365 (company) — SEC File Number
  • 950 N. Glebe Rd., Suite 700 (location) — Principal Executive Offices Address
  • Arlington, Virginia (location) — Principal Executive Offices City and State

FAQ

What is the primary purpose of this 8-K filing for Privia Health Group, Inc.?

The primary purpose of this 8-K filing is to report a Regulation FD Disclosure and to provide Financial Statements and Exhibits, as indicated in the filing information.

On what date was this 8-K filing reported as of?

This 8-K filing was reported as of January 13, 2025.

What is the SEC file number for Privia Health Group, Inc.?

The SEC file number for Privia Health Group, Inc. is 001-40365.

Where are Privia Health Group, Inc.'s principal executive offices located?

Privia Health Group, Inc.'s principal executive offices are located at 950 N. Glebe Rd., Suite 700, Arlington, Virginia 22203.

Does this 8-K filing announce any specific material events or financial results?

This 8-K filing does not specify any particular material events or financial results beyond the general categories of Regulation FD Disclosure and Financial Statements and Exhibits.

Filing Stats: 608 words · 2 min read · ~2 pages · Grade level 10.5 · Accepted 2025-01-13 08:47:22

Key Financial Figures

  • $0.01 — ange on which registered Common Stock, $0.01 par value per share PRVA The Nasdaq Glo

Filing Documents

01 Regulation FD Disclosure

Item 7.01 Regulation FD Disclosure. We are furnishing this Current Report on Form 8-K to furnish materials that will be provided at meetings with institutional investors or analysts. The materials are attached as Exhibit 99.1 to this Current Report on Form 8-K, are incorporated into this Item 7.01 by reference and are available on our investor relations website at ir.priviahealth.com . This information may be amended or updated at any time and from time to time through another Current Report on Form 8-K, a later company filing, or other means. The information in this Current Report on Form 8-K (including the exhibit) is furnished pursuant to Item 7.01 and shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section. This Current Report on Form 8-K will not be deemed an admission as to the materiality of any information in the Report that is required to be disclosed solely by Regulation FD. We do not have, and expressly disclaim, any obligation to release publicly any updates or any changes in our expectations or any change in events, conditions, or circumstances on which any forward-looking statement is based.

01 Financial Statements and Exhibits

Item 9.01 Financial Statements and Exhibits. (d) Exhibit: Exhibit No. Description 99.1 Privia Health Group, Inc. Investor Presentation Slides - January 2025 104 Cover Page Interactive Data File (formatted as Inline XBRL)

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. PRIVIA HEALTH GROUP, INC. Date: January 13, 2025 By: /s/ David Mountcastle Name: David Mountcastle Title: Executive Vice President, Chief Financial Officer and Authorized Officer

View Full Filing

View this 8-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.